loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
.
as new waves of violence started in rakhine state in august previous year, there were widespread reports of rape and sexual violence against women and girls.
.